Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02328014 |
| Title | ACP-196 in Combination With ACP-319, for Treatment of B-Cell Malignancies |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Acerta Pharma BV |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Orange | California | 92868 | United States | Details | |
| Research Site | Bethesda | Maryland | 20892 | United States | Details | |
| Research Site | Rochester | New York | 14642 | United States | Details | |
| Research Site | Portland | Oregon | 97239 | United States | Details | |
| Research Site | Nashville | Tennessee | 37203 | United States | Details | |
| Research Site | Austin | Texas | 78705 | United States | Details | |
| Research Site | Seattle | Washington | 98109 | United States | Details |